Oriola Corp (FRA:O5O) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amid ERP Challenges

GuruFocus News

Thu, February 26, 2026 at 12:00 AM GMT+9 3 min read

In this article:

O5O.F

-0.72%

This article first appeared on GuruFocus.

**Net Sales Increase:** 14% growth in net sales.

**Adjusted EBITDA:** Increased to EUR35.1 million, exceeding the previous year's level.

**Distribution Segment Net Sales Growth:** 11% increase, driven by existing and new customers.

**Wholesale Segment Net Sales Growth:** 26% increase, driven by parallel import and weight loss medicines in Sweden, and veterinarians and special licensed medicines in Finland.

**Adjusted EBITDA for Distribution Segment:** Increased from EUR8.1 million to EUR8.8 million in Q4.

**Adjusted EBITDA for Wholesale Segment:** Increased from EUR2.7 million to EUR2.8 million in Q4.

**Net Profit:** Minus EUR27.2 million, affected by ERP project costs, impairments, and results from Kronans Apotek.

**Free Cash Flow:** EUR58.4 million, compared to EUR43.4 million last year.

**Net Debt:** Minus EUR82 million, with cash and cash equivalents of EUR152 million.

**Dividend Proposal:** EUR0.03 per share for 2025, with an additional authorization for up to EUR0.04 in November 2026.

Warning! GuruFocus has detected 6 Warning Signs with FRA:O5O.

Is FRA:O5O fairly valued? Test your thesis with our free DCF calculator.

Release Date: February 25, 2026

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

Oriola Corp (FRA:O5O) achieved a 14% increase in net sales for 2025, driven by strong performance in both distribution and wholesale segments.

The company reported an improved adjusted EBITDA of EUR 35.1 million, surpassing the previous year's level.

Customer satisfaction reached an all-time high, with significant improvements in Net Promoter Score due to enhanced customer relationships and service offerings.

The integration of the joint venture company, Kronans Apotek, has been completed, setting a foundation for future growth and strategic initiatives.

Oriola Corp (FRA:O5O) is investing in a new state-of-the-art distribution center in Jarvenpaa, Finland, which will enhance logistics capabilities and support long-term growth and sustainability goals.

Negative Points

The ERP project has incurred significant costs, impacting the reported EBITDA negatively, with a decline from EUR 7 million to EUR 5.8 million in Q4.

Kronans Apotek's profitability remains below industry benchmarks, with ongoing challenges in reaching desired market levels.

The equity ratio has decreased to 10.8%, influenced by ERP project costs and impairments related to Kronans Apotek.

The wholesale segment's profitability has been affected by a sales mix of lower-margin products and growth investments.

Oriola Corp (FRA:O5O) faces uncertainties in customer confidence and market demand, particularly in the wholesale segment, which could impact future growth.

 






繼續閱讀  

Q & A Highlights

Q: Could you explain the press release on January 7 regarding strengthening and maintaining a reasonable equity level? When will Oriola pursue buybacks and divestments? A: Mats Danielsson, CFO: We have a large balance sheet and a stable underlying business. We are not currently pursuing buybacks, but it’s part of our toolbox. No divestments have been reported so far.

Q: How much of the ERP project is currently in use, and what impact has it had on P&L? A: Katarina Gabrielson, CEO: A small part of the ERP system is in use in Sweden, focusing on logistics. The full impact on P&L is still being assessed as the project is ongoing.

Q: What is the importance of the equity ratio to Oriola? A: Mats Danielsson, CFO: The equity ratio is crucial for any company. Our current lower ratio is due to one-off costs from the ERP project and Kronans impairments. We expect a correction post-transformation.

Q: Can Oriola continue on a track of double-digit growth this year? A: Katarina Gabrielson, CEO: While we aim to improve profitability, we are pushing for growth. However, we do not specifically guide on achieving double-digit growth.

Q: What factors should be considered for margin development expectations in the wholesale segment? A: Katarina Gabrielson, CEO: Our own brands showed positive signs towards the end of 2025. We anticipate growth in listings and sales, especially in grocery and retail, which should support future margin development.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

條款 及 私隱政策

Privacy Dashboard

More Info